Rubius Therapeutics Inc. sell WatchMen
Start price
26.12.21
/
0%
€9.60
Target price
26.12.22
-
Performance (%)
-98.17%
End price
27.12.22
€0.18
Summary
This prediction ended on 27.12.22 with a price of €0.18. WatchMen correctly predicted massive losses of -98.17% for Rubius Therapeutics Inc.. This prediction was marked as speculative and is excluded from WatchMen's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rubius Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% | 58.545% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% | 80.511% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% | 62.776% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% | 54.389% |
Comments by WatchMen for this prediction
In the thread Rubius Therapeutics Inc. diskutieren
Sell Rubius Therapeutics Inc.
In the thread Trading Rubius Therapeutics Inc.
Die von WatchMen gewählte maximale Laufzeit wurde überschritten